Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of Tegaserod in Opioid-Induced Constipation in Patients With Non-Cancer Pain.
This study has been terminated.
( This study was terminated early as a result of regulatory action suspending tegaserod use in 2007 )
Study NCT00399659   Information provided by Novartis
First Received: November 14, 2006   Last Updated: April 1, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Opioid-Induced Constipation
Additional conditions recognized in this trial
Constipation
More general conditions related to this trial
Signs and Symptoms
Signs and Symptoms, Digestive
Interventions listed in this trial
Tegaserod
Additional drug interventions recognized in this trial
Analgesics, Opioid
More general drug interventions related to this trial
Analgesics
Central Nervous System Agents
Central Nervous System Depressants
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Serotonin Agents
Serotonin Agonists
Therapeutic Uses
Sponsors listed in this trial
Novartis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services